Etanercept and demyelinating disease in a patient with psoriasis

Journal of the American Academy of Dermatology

Volumn 54, Issue 1, 2006, Pages 160-164

  Sukal, Sean A ^a   Nadiminti, Lakshmi ^a   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; BLURRED VISION; CASE REPORT; DEMYELINATING DISEASE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; HYPERREFLEXIA; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS;

ADOLESCENT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 29244457210     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.05.039     Document Type: Article

References (41)

1. Enbrel [package insert]. Thousand Oaks, CA: Immunex; 2005.
2. C.L. Leonardi, J.L. Powers, R.T. Matheson, B.S. Goffe, R. Zitnik, and A. Wang Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2003 2014 2022
3. P.J. Mease, B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, and D.J. Burge Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial Lancet 356 2000 385 390
4. B.E. Strober, and S. Clarke Etanercept for the treatment of psoriasis: combination therapy with other modalities J Drugs Dermatol 3 2004 270 272
5. B.E. Strober Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab Arch Dermatol 140 2004 366
6. P.S. Yamauchi, V. Gindi, and N.J. Lowe The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety Dermatol Clin 22 2004 449 459 ix
7. F.M. Hofman, D.R. Hinton, K. Johnson, and J.E. Merrill Tumor necrosis factor identified in multiple sclerosis brain J Exp Med 170 1989 607 612
8. M.K. Sharief, and R. Hentges Association between tumor necrosis factor-alpha and disease and disease progression in patients with multiple sclerosis N Engl J Med 325 1991 467 472
9. D. Maimone, S. Gregory, B.G.W. Arnason, and A.T. Reder Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis J Neuroimmunol 32 1991 67 74
10. C. Lock, J. Oksenberg, and L. Steinman The role of TNF and lymphotoxin in demyelinating disease Ann Rheum Dis 58 Suppl 1 1999 I121 I128
11. K.W. Selmaj, and C.S. Raine Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro Ann Neurol 23 1988 339 346
12. K.W. Selmaj, M. Farooq, W.T. Norton, C.S. Raine, and C.F. Brosnan Proliferation of astrocytes in vitro in response to cytokine: a primary role for tumor necrosis factor J Immunol 144 1990 129 135
13. N. Mohan, E.T. Edwards, T.R. Cupps, P.J. Oliverio, G. Sandberg, and H. Crayton Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides Arthritis Rheum 44 2001 2862 2869
14. T. Owens, H. Wekerle, and J. Antel Genetic models for CNS inflammation Nat Med 7 2001 161 166
15. T. Owens, and S. Sriram The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis Neurol Clin 13 1995 51 73
16. Y. Kuroda, and Y. Shimamoto Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats J Neuroimmunol 34 1991 159 164
17. N.H. Ruddle, C.M. Bergman, K.M. McGrath, E.G. Lingenheld, M.L. Grunnet, and S.J. Padula An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis J Exp Med 172 1990 1193 1200
18. K. Selmaj, C.S. Raine, and A.H. Cross Anti-tumor necrosis factor abrogates autoimmune demyelination Ann Neurol 30 1991 694 700
19. D. Baker, D. Butler, B.J. Scallon, J.K. O'Neill, J.L. Turk, and M. Feldmann Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins Eur J Immunol 24 1994 2040 2048
20. W.E. Klinkert, K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, and H. Wekerle TNF-alpha receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview J Neuroimmunol 72 1997 163 168
21. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept multiple sclerosis study group and The University of British Columbia MS/MRI Analysis Group Neurology 53 1999 457 465
22. B.W. van Oosten, F. Barkhof, L. Truyen, J.B. Boringa, F.N. Bertelsmann, and B.M. von Blomberg Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 Neurology 47 1996 1531 1534
23. V. Taupin, T. Renno, L. Bourbonniere, A.C. Peterson, M. Rodriguez, and T. Owens Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system Eur J Immunol 27 1997 905 913
24. L. Probert, K. Akassoglou, G. Kassiotis, M. Pasparakis, L. Alexopoulou, and G. Kollias TNF-alpha transgenic and knockout models of CNS inflammation and degeneration J Neuroimmunol 72 1997 137 141
25. A.K. Stalder, M.J. Carson, A. Pagenstecher, V.C. Asensio, C. Kincaid, and M. Benedict Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor Am J Pathol 153 1998 767 783
26. A.J. Bruce, W. Boling, M.S. Kindy, J. Peschon, P.J. Kraemer, and M.K. Carpenter Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors Nat Med 2 1996 788 794
27. K. Akassoglou, J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, and G. Kollias Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy Am J Pathol 153 1998 801 813
28. H.P. Eugster, K. Frei, R. Bachmann, H. Bluethmann, H. Lassmann, and A. Fontana Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1 Eur J Immunol 29 1999 626 632
29. J.D. Sedgwick, D.S. Riminton, J.G. Cyster, and I. Korner Tumor necrosis factor: a master-regulator of leukocyte movement Immunol Today 21 2000 110 113
30. J. Liu, M.W. Marino, G. Wong, D. Grail, A. Dunn, and J. Bettadapura TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination Nat Med 4 1998 78 83
31. E. Douni, and G. Kollias A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin a, or the p55TNF-R J Exp Med 188 1998 1343 1352
32. G. Kollias, E. Douni, G. Kassiotis, and D. Kontoyiannis The function of tumor necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease Ann Rheum Dis 59 Suppl 1 1999 132 139
33. H.P. Hartung, K. Reiners, J.J. Archelos, M. Michels, P. Seeldrayers, and F. Heidenreich Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging Ann Neurol 38 1995 186 193
34. W.H. Robinson, M.C. Genovese, and L.W. Moreland Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44 2001 1977 1983
35. A. Cope, R. Ettinger, and H. McDevitt The role of TNF and related cytokines in the development and function of the autoreactive T-cell repertoire Res Immunol 148 1997 307 312
36. L. Klareskog, and H. McDevitt Rheumatoid arthritis and its animal models: the role of TNF- and the possible absence of specific immune reactions Curr Opin Immunol 11 1999 657 662
37. E.A. Green, and R. Flavell Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice Immunol Rev 169 1999 11 12
38. A.N. Theofilopoulos, and B.R. Lawson Tumor necrosis factor and other cytokines in murine lupus Ann Rheum Dis 58 Suppl 1 1999 149 155
39. M. Cisternas, M. Gutierrez, and S. Jacobelli Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al Arthritis Rheum 46 2002 3107 3108
40. R. Midgard, M. Gronning, T. Riise, G. Kvale, and H. Nyland Multiple sclerosis and chronic inflammatory disease: a case-control study Acta Neurol Scand 93 1996 322 328
41. P. Annunziata, P. Morana, A. Giorgio, M. Galeazzi, V. Campanella, and F. Lore High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort Acta Neurol Scand 108 2003 327 331